InsidersTradesSigma
Follow the AroCell AB (publ) stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Market capitalisation: €112.9m. The latest transaction was disclosed on 19 January 2021 (Purchase). Among the most active insiders: Anders Hultman. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
AroCell AB (publ) is a Swedish company focused on developing diagnostic tests for cancer. It is listed on the Stockholm Stock Exchange under the symbol XSTO.